Pay in 4 interest-free payments of $166.62 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Using new therapeutics that block the PD-L1:PD-1 interaction has proven successful in the clinic for many cancer types and has sparked great interest in the field of cancer immunotherapy
the master regulator of iron absorption and distribution in the body
L medium containing 10% fetal bovine serum or the desired chemoattractant
it is localized in the secretory sacs of neurons and endocrine cells
The CRDs are linked to a small peptide domain
MTBR-Tau243 (225-242) Recombinant Rabbit mAb (SDT-2033-13) Size:1mg Using new therapeutics that blockProduct Specification Host Rabbit Antigen MTBR Tau243 Synonyms microtubule binding region containing residue 243 Immunogen Synthetic Peptide Accession P10636 8 Clone Number SDT 2033 13 Antibody Type Recombinant mAb Isotype IgG Application ELISA, Competitive ELISA Reactivity Hu Cross Reactivity No cross reactivity against Tau peptide (aa225 243), it shows good binding ability with Tau peptide (aa225 242). Purification Protein A Concentration 2 mg ml
US$ 45.60
US$ 13.20
US$ 21.60
US$ 14.40
US$ 70.80